Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1997 Aug;43:1376–1381.

Do physicians discuss HIV testing during prenatal care?

G Ogilvie 1, S Adsett 1, G Macdonald 1
PMCID: PMC2255416  PMID: 9266122

Abstract

OBJECTIVE: To determine the frequency with which Hamilton, Ont, general practitioners and family physicians discussed and offered HIV testing during prenatal care. DESIGN: Cross-sectional mailed survey. SETTING: Family physicians' and general practitioners' offices in Hamilton, including group or solo private practices and community health centres. PARTICIPANTS: General practitioners and family physicians in Hamilton identified from the Ontario Medical Association and the 1995 Canadian Medical Directory. Two hundred forty-one practitioners were sent surveys; 25% had moved or no longer practised family medicine, and 65% (140 of 216) were returned. MAIN OUTCOME MEASURE: Frequency with which physicians discuss with and offer HIV testing to prenatal patients. RESULTS: Eighty percent of clinicians felt they understood their professional role in providing HIV testing, and more than 90% had referred female patients for HIV testing. Eight percent of physicians always discussed HIV when reviewing pregnancy care, and 5% always offered HIV testing to patients in the first trimester of pregnancy. CONCLUSIONS: Currently, few physicians discuss HIV testing with all their prenatal patients.

Full text

PDF
1376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacci M. B., Dalabetta G. A., Repke J. T., Talbot B. L., Charache P., Polk B. F., Chaisson R. E. Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening. Sex Transm Dis. 1990 Jul-Sep;17(3):122–126. doi: 10.1097/00007435-199007000-00002. [DOI] [PubMed] [Google Scholar]
  2. Bueckert H. Costs and benefits of screening pregnant women for HIV. CMAJ. 1996 Nov 15;155(10):1387–1387. [PMC free article] [PubMed] [Google Scholar]
  3. Chrystie I. L., Zander L., Tilzey A., Wolfe C. D., Kenney A., Banatvala J. E. Is HIV testing in antenatal clinics worthwhile? Can we afford it? AIDS Care. 1995;7(2):135–145. doi: 10.1080/09540129550126650. [DOI] [PubMed] [Google Scholar]
  4. Coates R. A., Frank J. W., Arshinoff R., Major C., Wallace E., Millson M. E., McLaughlin B., Demshar H., Khazen R., Garbutt J. The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med. 1992 Feb;15(1):1–7. [PubMed] [Google Scholar]
  5. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  6. Davis D. A., Thomson M. A., Oxman A. D., Haynes R. B. Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. JAMA. 1992 Sep 2;268(9):1111–1117. [PubMed] [Google Scholar]
  7. Fehrs L. J., Hill D., Kerndt P. R., Rose T. P., Henneman C. Targeted HIV screening at a Los Angeles prenatal/family planning health center. Am J Public Health. 1991 May;81(5):619–622. doi: 10.2105/ajph.81.5.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gorsky R. D., Farnham P. G., Straus W. L., Caldwell B., Holtgrave D. R., Simonds R. J., Rogers M. F., Guinan M. E. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention. Public Health Rep. 1996 Jul-Aug;111(4):335–341. [PMC free article] [PubMed] [Google Scholar]
  9. Hankins C. A., Laberge C., Lapointe N., Lai Tung M. T., Racine L., O'Shaughnessy M. HIV infection among Quebec women giving birth to live infants. CMAJ. 1990 Nov 1;143(9):885–893. [PMC free article] [PubMed] [Google Scholar]
  10. MacDonald K. L., Jackson J. B., Bowman R. J., Polesky H. F., Rhame F. S., Balfour H. H., Jr, Osterholm M. T. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med. 1989 Apr 15;110(8):617–621. doi: 10.7326/0003-4819-110-8-617. [DOI] [PubMed] [Google Scholar]
  11. Rowan M. S., Toombs M., Bally G., Walters D. J., Henderson J. Qualitative evaluation of the Canadian Medical Association's counselling guidelines for HIV serologic testing. CMAJ. 1996 Mar 1;154(5):665–671. [PMC free article] [PubMed] [Google Scholar]
  12. Schechter M. T., Ballem P. J., Buskard N. A., Le T. N., Thompson M., Marion S. A., O'Shaughnessy M. V. An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory. CMAJ. 1990 Dec 1;143(11):1187–1192. [PMC free article] [PubMed] [Google Scholar]
  13. Skotniski E. M., Woodward C., Hutchison B., Abelson J., Brown J., Norman G. HIV testing practices of primary care physicians: an Ontario survey. Can J Public Health. 1996 May-Jun;87(3):172–175. [PubMed] [Google Scholar]
  14. Wilfert C. M. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis. 1994 Oct;19(4):664–666. doi: 10.1093/clinids/19.4.664. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES